Decoding and targeting the molecular basis of MACC1-driven metastatic spread: Lessons from big data mining and

Jan Budczies1, Klaus Kluck2, Wolfgang Walther3

  • 1Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany; German Cancer Consortium, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Insights

Metastasis-associated gene MACC1 interacts with key genes like MET, HGF, and MMP7 across many cancers. Big data analysis reveals new potential gene targets and transcription factors for combination cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Metastasis is a critical challenge in cancer patient survival and treatment efficacy.
  • Metastatic spread involves complex cellular processes and numerous associated genes.
  • The metastasis-associated gene MACC1 plays a role in this process.

Purpose of the Study:

  • To investigate the cooperative interactions of MACC1 with other genes in metastatic spread.
  • To identify potential combination therapies by understanding these gene coactions.
  • To uncover transcriptional regulation mechanisms activated with MACC1.

Main Methods:

  • Correlation analysis of MACC1 mRNA expression across 33 cancer types using TCGA data.
  • Comprehensive literature search for MACC1 combinations and regulatory mechanisms.
  • Identification of shared transcription factor binding motifs in promoter regions of MACC1-correlating genes.

Main Results:

  • Significant positive correlations between MACC1 and MET, HGF, and MMP7 in over half of analyzed cancer types.
  • Identification of 1306 positively and 590 negatively MACC1-correlating genes.
  • Enrichment of binding sites for transcription factors TELF1, ETS2, ETV4, TEAD1, FOXO4, NFE2L1, ELK1, SP1, and NFE2L2, with SP1 being previously reported in combination with MACC1.

Conclusions:

  • Big data analysis partially aligns with existing experimental findings on MACC1.
  • New hypotheses on genes involved in MACC1-driven metastasis can be generated for experimental validation.
  • Results can guide prioritization of cancer types for further research and combination therapy development.

Related Concept Videos

Correlation of Experimental Data01:23

Correlation of Experimental Data

Dimensional analysis simplifies complex physical problems and guides experimental investigations, but it does not provide complete solutions. It identifies the dimensionless groups that influence a phenomenon, but experimental data is needed to establish the specific relationships and validate theoretical predictions.
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
480
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.3K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
534
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
250
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
323